Results showed that activated macrophages release sEVs containing miR-155, which are taken up by TECs, directly target SOCS1, and enhance NF-κB signaling, thereby intensifying inflammation and AKI progression [132]. The gene discussed is SOCS1; the disease is acute kidney injury.